Kenneth J. Kelley, Director at HALOZYME THERAPEUTICS INC (HALO), bought 20,000 shares at $7.49 ($150K) on 2012-05-14, disclosed to the SEC on 2012-05-16.
Seasonal purchase ($150k) by Director — this insider has traded HALO in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| HALO | SELL | 2021-02-01 | $469K | — | Filing → |
| HALO | SELL | 2021-01-04 | $417K | — | Filing → |
| HALO | SELL | 2020-12-07 | $1.4M | — | Filing → |